DECIPHERA PHARMACEUTICALS IN (DCPH)
US24344T1016 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -194.94M | -178.93M | -299.96M | -266.49M | -192.26M | |||
| Depreciation Amortization | 2.10M | 2.95M | 3.01M | 2.31M | 830.00K | |||
| Income Taxes - Deferred | N/A | 722.00K | N/A | N/A | N/A | |||
| Change In Working Capital | -1.54M | -32.37M | 820.00K | -13.85M | 24.76M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 67.00K | |||
| Other non cash items | 47.68M | 54.77M | 55.31M | 38.35M | 17.37M | |||
| OPERATING CASH FLOW | -146.70M | -152.86M | -240.82M | -239.68M | -149.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -778.00K | -841.00K | -5.97M | -5.32M | -4.93M | |||
| Other Investing Activity | 13.33M | -33.47M | 182.82M | 33.77M | -455.59M | |||
| INVESTING CASH FLOW | 12.55M | -34.31M | 176.85M | 28.46M | -460.52M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -1.29M | |||
| Stock Issued/Repurchased | 152.64M | 165.42M | 14.93M | 227.62M | 438.29M | |||
| Other Financing Activity | -634.00K | -425.00K | -40.00K | -815.00K | -620.00K | |||
| FINANCING CASH FLOW | 152.00M | 164.99M | 14.89M | 226.80M | 436.37M | |||
| Exchange Rate Effect | 910.00K | -145.00K | 252.00K | N/A | N/A | |||
| CHANGE IN CASH | 18.77M | -22.32M | -48.83M | 15.58M | -173.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -146.70M | -152.86M | -240.82M | -239.68M | -149.30M | |||
| Capital Expenditure | -778.00K | -841.00K | -5.97M | -5.32M | -4.93M | |||
| FREE CASH FLOW | -147.47M | -153.70M | -246.79M | -245.00M | -154.23M | |||
All data in USD